These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients. Lachowicz D; Szulencka G; Obuch-Woszczatyński P; van Belkum A; Pituch H Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):63-67. PubMed ID: 25060801 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015. Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487 [No Abstract] [Full Text] [Related]
5. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18. Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826 [TBL] [Abstract][Full Text] [Related]
6. The burden of Clostridioides difficile infections in South-East Asia and the Western Pacific: A narrative review. Angulo FJ; Ghia C; Fletcher MA; Ozbilgili E; Morales GDC Anaerobe; 2024 Apr; 86():102821. PubMed ID: 38336258 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835 [TBL] [Abstract][Full Text] [Related]
8. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study. Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M; Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507 [TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of, and Antimicrobial Resistance in, Imwattana K; Putsathit P; Knight DR; Kiratisin P; Riley TV Microb Drug Resist; 2021 Nov; 27(11):1505-1512. PubMed ID: 33956520 [TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937 [TBL] [Abstract][Full Text] [Related]
11. Defining the phylogenetics and resistome of the major O'Grady K; Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Levy A; Moore CV; Nimmo G; Prendergast L; Robson J; Speers DJ; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR Microb Genom; 2024 May; 10(5):. PubMed ID: 38717815 [No Abstract] [Full Text] [Related]
12. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities. Jon J V; Mark H W; Jane F Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922 [TBL] [Abstract][Full Text] [Related]
13. Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland. Obuch-Woszczatyński P; Dubiel G; Harmanus C; Kuijper E; Duda U; Wultańska D; van Belkum A; Pituch H Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1027-30. PubMed ID: 23443474 [TBL] [Abstract][Full Text] [Related]
14. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Tickler IA; Goering RV; Whitmore JD; Lynn AN; Persing DH; Tenover FC; Antimicrob Agents Chemother; 2014 Jul; 58(7):4214-8. PubMed ID: 24752264 [TBL] [Abstract][Full Text] [Related]
15. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis. Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531 [TBL] [Abstract][Full Text] [Related]
16. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH; Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403 [TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China. Wang B; Lv Z; Zhang P; Su J Medicine (Baltimore); 2018 Jun; 97(25):e11219. PubMed ID: 29924052 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital. Zhang RF; Man YX; Bai YY; Shao CH; Liu CM; Wang CH; Lei YX; Wang Y; Jin Y J Microbiol Immunol Infect; 2021 Dec; 54(6):1179-1183. PubMed ID: 33563561 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010. Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338 [TBL] [Abstract][Full Text] [Related]
20. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Hawes AM; Desai A; Patel PK Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]